Work

Novel transcatheter aortic valve replacement devices

Year: 2024

Type: article

Abstract: Transcatheter aortic valve replacement (TAVR) has revolutionized the management of aortic stenosis (AS), offering a less-invasive alternative to surgical aortic valve replacement. Since its approval in the United States in 2011 for patients with severe AS at high or extreme surgical risk, TAVR has undergone continuous advancements. Early-generation TAVR devices prioritized reducing periprocedural complications like paravalvular leak, stroke, and major vascular complications. These complications have become increasingly uncommon due to iterative improvements in device design.

Source: JTCVS structural and endovascular.

DOI: 10.1016/j.xjse.2024.100040

Authors: Ankur Sethi, Mark Russo

Institutions: Robert Wood Johnson University Hospital, Rutgers, The State University of New Jersey

Language: English

Topic: Cardiac Valve Diseases and Treatments

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,500